| Benjamin Foust, PHARMD | |
|
1750 W Traverse Pkwy, Lehi, UT 84043-5978 | |
| (385) 352-8018 | |
| (385) 352-8019 |
| Full Name | Benjamin Foust |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 1750 W Traverse Pkwy, Lehi, Utah |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1154040103 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 8675695-1701 (Utah) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Benjamin Foust, PHARMD 1084 E Quarry View Way, Sandy, UT 84094-7709 Ph: (801) 615-1150 | Benjamin Foust, PHARMD 1750 W Traverse Pkwy, Lehi, UT 84043-5978 Ph: (385) 352-8018 |
News Archive
Being overweight leads to a greater risk of miscarriage for patients undergoing assisted reproductive technology (ART), the 26th annual conference of the European Society of Human Reproduction and Embryology heard today (Monday). Dr. Vivian Rittenberg, a Clinical Fellow in the Assisted Conception Unit, Guy's and St. Thomas' Hospital NHS Foundation Trust, London, UK, said that her research provided additional evidence to show that increased body mass index (BMI) was independently associated with a higher miscarriage rate after IVF or ICSI treatment.
Immune Pharmaceuticals Inc., a clinical stage biopharmaceutical company that engages in the development and commercialization of targeted therapeutics for the treatment of inflammatory diseases and cancer, today completed the underwriter's exercise of partial over-allotment option of 459,697 units, at a price of $2.50 per unit, for gross proceeds of approximately $1.06 million, bringing the aggregate gross proceeds of the Company's previously announced underwritten public offering to $9.685 million.
A national Radiation Therapy Oncology Group (RTOG) study led by a Medical College of Wisconsin Cancer Center physician at Froedtert Hospital in Milwaukee has found that a course of radiation therapy to the brain after treatment for locally advanced non-small cell lung cancer reduced the risk of metastases to the brain within the first year after treatment. The study was presented at the American Society of Clinical Oncology annual meeting in Orlando, June 1.
GTCR, a leading private equity firm, today announced it has successfully completed the acquisition of Sterigenics International, Inc., the leading global provider of contract sterilization and ionization services for medical devices, food products, and advanced applications, from Silverfleet Capital and PPM America Capital Partners.
Stereotaxis, Inc. announced today that the Company has closed on its previously announced $40 million credit facility, which includes a $30 million revolving facility that matures on March 31, 2012 and a $10 million term loan that matures on December 31, 2013. The new facility was led by Silicon Valley Bank, and replaces the Company's previous facility that was scheduled to mature in March 2011.
› Verified 3 days ago
Mr. Jerry A Shields, R.PH.,M.B.A Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1584 W 900 N, Lehi, UT 84043 Phone: 801-580-4509 | |
Diane Bezzant Ogborn, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1550 E 3500 N, Lehi, UT 84043 Phone: 801-341-6515 Fax: 801-341-6516 | |
Timothy Nelson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 198 N 1200 E, Lehi, UT 84043 Phone: 801-653-2709 | |
Dr. Adam Wilson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1250 Bridalwood Loop, Lehi, UT 84043 Phone: 208-206-1568 | |
Dr. Jason Richard Cook I, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 102 N 1200 E, Lehi, UT 84043 Phone: 801-653-2090 | |
Ms. Jennifer Kay Homer, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 590 E 1540 S, Lehi, UT 84043 Phone: 801-706-9726 |